Acute and chronic treatments of mice with the glutathione-depleting agent, L-buthionine-(SR)-sulfoximine (BSO), impaired the mineralocorticoid receptor (MR)-dependent biological response by inhibiting aldosterone binding. This steroid-binding inhibition was fully reversed when reducing agents were added to kidney cytosol obtained from mice treated for 5 h, but it was only partially reversed in cytosol obtained from mice treated for 10 days. Although the oligomeric structure of the MR-hsp90 heterocomplex was always unaffected, a decreased amount of MR protein was evidenced after the long term treatment. Such a deleterious effect was correlated with a post-translational modification of MR, as demonstrated by an increased level of receptor carbonylation. In addition, a failure at the elongation/termination step was also observed during the receptor translation process in a reticulocyte lysate system. Thus, a high polyribosomes/monomers ratio and both increased proteolysis and decreased ADP-ribosylatable concentration of elongation factor 2 (EF-2) were shown. Importantly, similar observations were also performed in vivo after depletion of glutathione. Notwithstanding the EF-2 functional disruption, not all renal proteins were equally affected as the MR. Interestingly, both EF-2 and MR expressed in old mice were similarly affected as in L-buthionine-(SR)-sulfoximine-treated young mice. We therefore propose that a dramatic depletion of glutathione in kidney cells mimics the cumulative effect of aging which, at the end, may lead to a renal mineralocorticoid dysfunction.The biological effects of aldosterone (ALDO) 1 are mediated by the mineralocorticoid receptor (MR), a ligand-dependent transcription factor that belongs to the steroid receptor class of nuclear receptors. The transcriptional activation of the MR in epithelial cells triggers a series of events that are responsible for the regulation of the internal medium, i.e. Na ϩ and H 2 O retention and K ϩ and H ϩ elimination. Steroid receptors exist as nuclear or cytoplasmic heterocomplexes associated to the 90-kDa heat shock protein (hsp90) chaperone system (1, 2). Regardless of its subcellular localization, this association stabilizes the receptor in its hormone binding and transcriptionally inactive form. It is thought that upon ligand binding, the steroid receptors undergo a conformational change that leads to the dissociation of the hsp90-heterocomplex, dephosphorylation, dimerization, translocation into the nucleus (for cytoplasmic receptors), hyperphosphorylation, and binding to specific hormone-responsive elements. Nonetheless, the actual temporal sequence of this cascade of events remains unclear. In contradiction to what was previously thought, it has been shown that the dissociation of the hsp90-heterocomplex upon steroid binding is not necessarily the first step in the signaling pathway (3, 4). Consistent with this observation, it has also been postulated that the receptorhsp90 complex requires intact cytoskeletal tracks to move efficiently toward the n...